Cite
HARVARD Citation
Curtis, J. et al. (2014). FRI0065 Incidence of Interstitial Lung Disease in Rheumatoid Arthritis Patients Receiving Tocilizumab, Rituximab, Abatacept and Anti-Tumor Necrosis Factor Alpha Agents. Annals of the rheumatic diseases. p. 405. [Online].